Last reviewed · How we verify

NCT07134049: SI-BPI

Sensory Integration Therapy in Children With Congenital Brachial Plexus Injury: Developmental Outcomes

Recruiting now NA Last updated 21 August 2025
What this trial tests

NA trial testing sensory integration therapy in Obstetric Brachial Plexus Injury in 30 participants. Currently enrolling.

Timeline
23 June 2025
Primary endpoint
31 July 2026
31 December 2026

Quick facts

Lead sponsorHacettepe University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment30
Start date23 June 2025
Primary completion31 July 2026
Estimated completion31 December 2026
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Hacettepe University

Who can join

Adults 7 Months to 35 Months, any sex, with Obstetric Brachial Plexus Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to investigate the effectiveness of sensory integration therapy in reducing sensory, motor, and cognitive developmental impairments following Congenital Brachial Plexus Injury (CBPI), and to support the overall developmental processes of affected children.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of sensory integration therapy

Trials testing the same drug.

Other recruiting trials for Obstetric Brachial Plexus Injury

Currently open trials in the same condition.

Other Hacettepe University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07134049.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing